Search
Search Results
##search.searchResults.foundPlural##
-
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
966PDF: 527HTML: 217 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3872PDF: 1961HTML: 246 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1325PDF: 511HTML: 208 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2425PDF: 1017HTML: 1655Fig 1: 197Tab I: 223Cover Letter: 216 -
Pseudo-differentiation syndrome
1404PDF: 680HTML: 10854Figure 1: peripheral blood showing myeloblasts with auer rods: 127Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 111Figure 3: CXR showing pulmonary infiltartes with consolidation: 140Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 122Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 121 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2175PDF: 1025HTML: 4081Cover Letter: 229Figure 1: 241Figure 2: 239Table 1: 212 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4493PDF: 1743HTML: 1093 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
769PDF: 891PDF Supp. Files: 80HTML: 196 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2081PDF: 784HTML: 3119 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1622PDF: 644HTML: 479 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4871PDF: 1827HTML: 2730Untitled: 234 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1431PDF: 837HTML: 8669Fig 3 Savini: 183Fig 2 Savini: 188Fig 1 Savini Chest TC: 194Author letter to referees: 196 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1257PDF: 611HTML: 2873ATRA induced Reactive Hemophagocytosis: A Case Report: 207 -
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1003PDF: 542HTML: 731 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4873PDF: 1856HTML: 2170 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1291PDF: 1035HTML: 234 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4112PDF: 1169HTML: 2004Fig.1: 223Fig. 2: 114Table 1: 209Table2: 228Table 3: 206 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1795PDF: 891HTML: 388Fig1: 245Fig.2: 261Fig. 3: 197Fig. 5: 209Fig. 4: 233 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4135PDF: 1272HTML: 1967Table 1: 209 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1610PDF: 1059HTML: 263 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1337PDF: 1030HTML: 127







